Primary Citation PubMed: 16480864
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
Thermodynamics of aryl-dihydroxyphenyl-thiadiazole binding to human Hsp90.
(2012) PLoS One 7
PubMed: 22655030 | PubMedCentral: PMC3360036 | DOI: 10.1371/journal.pone.0036899
ICPD inhibitors bear resorcinol group and should bind similarly to the naturally occurring compound radicicol (PDB ID 1bgq, energetics analyzed in  ) or inhibitors such as 4-chloro-6-(4-piperazin-... -yl-1h-pyrazol-3-yl)-benzene-1,2-diol (PDB ID 2ccs  ).
Publication Year: 2012
Co-crystalization and in vitro biological characterization of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazole Hsp90 inhibitors.
PubMed: 22984537 | PubMedCentral: PMC3439374 | DOI: 10.1371/journal.pone.0044642
For a variety of pyrazole and isoxazole inhibitors the conformation of the loop is either in an open (pdb 2BYI and 2BYH) or compact conformation (pdb 2CCU, 2VCJ, 2CCT, 2CCS, 2BSM and 2BT0).
Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application.
(2014) J Chem Inf Model 54
PubMed: 24555544 | PubMedCentral: PMC3985681 | DOI: 10.1021/ci400760a
Table 1 RMSD and AA Values Calculated between the Random (RC) and Experimental Conformations (EC) in the Realignment and Cross-Alignment Processes (RCRA and RCCA, Respectively) RCR... ECCA RCCA entry a PDB code RC vs EC EC vs all RC vs all 1 1UY8 0.46 0.37 0.52 2 1UYC 0.47 0.45 0.49 3 1UYD 0.7 0.36 0.43 4 1UYE 0.69 0.55 0.6 5 1UYG 0.41 0.74 0.65 6 1UYH 0.46 0.38 0.49 7 1UYK 0.62 0.26 0.56 13 2BT0 0.58 0.33 0.48 14 2CCS 0.46 0.64 0.74 16 2CCU 0.8 3.5 3.8 17 3B25 0.48 0.39 0.21 18 3B26 0.5 0.6 0.35 20 3B28 0.71 0.55 0.45 21 3OWB 0.65 0.74 0.7 22 3OWD 0.98 0.3 0.81 AA b 100 93.33 93.33 a Entry numbers are referred to those reported in Table 1 of reference ( 5 ) b Alignment accuracy, which refers to the fraction of correct and partially correct aligned structures (RMSD values of <2 Å and <3 Å, respectively), and it is explained by eq 1 .
Publication Year: 2014
FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.
(2014) Mol Cancer 13
PubMed: 24927996 | PubMedCentral: PMC4074137 | DOI: 10.1186/1476-4598-13-150
We then used Molsoft ICM 3.5a to model the interaction between Hsp90 (Protein Data Bank ID 2CCS) and FW-04-806 (Figure 1 D).
Identification of two novel HSP90 proteins in Babesia orientalis: molecular characterization, and computational analyses of their structure, function, antigenicity and inhibitor interaction.
(2014) Parasit Vectors 7
PubMed: 24970594 | PubMedCentral: PMC4089566 | DOI: 10.1186/1756-3305-7-293
Table 2 Interaction of Babesia orientalis HSP90-A and B isoforms with inhibitors using docking analysis Name Protein showing interaction Template ID PDB code Geldanamycin BoHSP90-A, BoHSP90-B Gmy1 2ex... Radamide BoHSP90-A, BoHSP90-B Rda1001 2gfd Redicicol BoHSP90-A, BoHSP90-B Rdc301 1u0z Dihydroxyphenylpyrazoles BoHSP90-A, BoHSP90-B 4BC401 1yc1 PU8(8-(2-chloro-3,4,5-trimethoxy-benzyl)-2-fluoro-9-pent-4-ylnyl-9 h-purin-6-ylamine) BoHSP90-B PU11224 1uyf PU11 (8-(2,5-dimethoxy-benzyl)-2-fluoro-9- pent-9 h-purin-6-ylamine) BoHSP90-A Puz1224 1uyi 1-(2-phenol)-2-naphthol BoHSP90-A, BoHSP90-B AB41226 2bz5 3,4-diaryl pyrazole resorcinol (CCT018159) BoHSP90-A, BoHSP90-B Ct51224 2bt0 4-amino derivative of 3,4-diaryl pyrazole (4-chloro-6-(4-piperazin-1-yl-1 h-pyrazol-3-yl)-benzene-1,2-diol) BoHSP90-B 4BH1224 2ccs The template IDs are the identification numbers of inhibitors in RCSB Protein Data Bank.
The RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics:
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.